Section A – KMP Resignation Details

Name of Resigning KMP: Mr. Nitin Agrawal

Designation: Chief Financial Officer & Key Managerial Personnel

Reason for Resignation: To pursue new professional opportunities that align more closely with long-term professional and personal growth.

Effective Date of Resignation: 30th September, 2026

Date of Resignation Letter: 30th July, 2026

Duration in Role: Not Specified

Board’s Acknowledgment / Statement: Not Specified

Replacement Appointed: Not Specified

Regulatory Compliance Statement: Disclosure made under Regulation 30(2) of SEBI LODR Regulations, read with SEBI Master Circular bearing No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated January 30, 2026. Full compliance with disclosure requirements including Annexure I details and enclosed resignation letter (Annexure II).

Delay in Disclosure: Not Specified

Section B – Additional Observations or Disclosures

Transition & Internal Role Reallocations: Mr. Agrawal remains fully committed to supporting management in ensuring a seamless handover of all ongoing strategic initiatives and will serve through 30 September 2026.

Strategic Initiatives Mentioned in Resignation Letter: Mr. Agrawal highlighted his involvement in several key strategic mandates during his tenure:

  • Building the MedTech business from the ground up
  • Acquisition of Adroit
  • Creation of Alkem Wellness
  • Formation of the Saudi joint venture
  • Acquisition of Bombay Ortho
  • Liquidation of idle assets including the Indore SEZ plant
  • Enhancement of rate of returns on treasury income
  • Implementation of new UCPMP marketing guidelines in the domestic market
  • Leading the acquisition of Occlutech (most recent)

Successor Appointments: Not Specified

Section C – Financial & Governance Disclosures

Audited Financial Results: Not Specified

Auditor’s Report Summary: Not Specified

Dividends / Capital Changes / Buybacks: Not Specified

Board / Committee Updates or Key Appointments: Not Specified

Company Details:

  • Date of Disclosure: 24th September, 2026
  • Compliance Officer: Manish Narang, President – Legal, Company Secretary & Compliance Officer